Publication | Closed Access

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

InfertilityHormonal ContraceptiveFemale InfertilityLuteinizing Hormone-releasing HormoneUterine ReceptivityGynecologyReproductive HormoneMenstrual CycleEndocrinologyMedicineNew Therapeutic ApproachReversible Hypogonadism